The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
ProShares
ETF
Equity
- years
225 holdings
$55.87
Price+0.75%
$0.41
$53.983m
Small
$13.606k
Avg Volume$82.688m
$62.18
NAV0.95%
Expense Ratio1.58%
Yield$0.88
Dividend